|
AP10463B-ev
|
Abcepta, Inc.
|
IL-12B [C-term] [RB28444], Rabbit Polyclonal Antibody
|
Human
|
WB, FC, IHC-P
|
|
|
AP10463B
|
Abcepta, Inc.
|
IL-12B [C-term] [RB28444], Rabbit Polyclonal Antibody
|
Human
|
WB, FC, IHC-P
|
|
|
PH304151
|
OriGene Technologies
|
Bone marrow stromal cell antigen 1 (BST1) (NM_004334) Human Mass Spec Standard
|
|
|
|
|
PH313683
|
OriGene Technologies
|
Cell adhesion molecule 4 (CADM4) (NM_145296) Human Mass Spec Standard
|
|
|
|
|
PH309047
|
OriGene Technologies
|
Host cell factor C1 regulator 1 (HCFC1R1) (NM_017885) Human Mass Spec Standard
|
|
|
|
|
PH300224
|
OriGene Technologies
|
Malignant T cell amplified sequence 1 (MCTS1) (NM_014060) Human Mass Spec Standard
|
|
|
|
|
PH303805
|
OriGene Technologies
|
Papillary renal cell carcinoma (PRCC) (NM_005973) Human Mass Spec Standard
|
|
|
|
|
PH306235
|
OriGene Technologies
|
Silencer of Death Domain (BAG4) (NM_004874) Human Mass Spec Standard
|
|
|
|
|
GTX48231-PRO
|
GeneTex International Corporation
|
Human Actin Gamma 1 protein
|
|
ELISA, WB, MS
|
|
|
GTX635712
|
GeneTex International Corporation
|
SARS-CoV-2 (COVID-19) nucleocapsid [HL455-MS], Mouse Monoclonal Antibody
|
SARS Coronavirus, SARS Coronavirus 2
|
WB, ICC/IF, ELISA, Sandwich ELISA, IHC-P (cell pellet)
|
|
|
GTX635712-S
|
GeneTex International Corporation
|
SARS-CoV-2 (COVID-19) nucleocapsid [HL455-MS], Mouse Monoclonal Antibody
|
SARS Coronavirus, SARS Coronavirus 2
|
WB, ICC/IF, ELISA, Sandwich ELISA, IHC-P (cell pellet)
|
|
|
P-1016-40
|
Epigentek Group Inc
|
Methylamp Whole Cell Bisulfite Modification Kit [40 samples]
|
|
Sample Modification
|
|
|
P-1016-80
|
Epigentek Group Inc
|
Methylamp Whole Cell Bisulfite Modification Kit [80 samples]
|
|
Sample Modification
|
|
|
HY-123023-25ug
|
MedChemexpress LLC
|
12(S)-HETE D8 [CAS 84807-90-9]
|
|
|
|
|
HY-140381-100mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-250mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-50mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-10mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-100mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-25mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-5mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-50mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-1g
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-100mg
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-500mg
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
